8K 4.23.13



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K

 


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report:  April 23, 2013
(Date of earliest event reported)
 
 


BIO-RAD LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
 

 


Commission File Number: 1-7928
 
Delaware
 
94-1381833
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
1000 Alfred Nobel Dr.
Hercules, California 94547
(Address of principal executive offices, including zip code)
 
(510) 724-7000
(Registrant’s telephone number, including area code)
 
 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))








ITEM 5.07
Submission of Matters to a Vote of Security Holders.


Bio-Rad Laboratories, Inc. (the “Company”) held its Annual Meeting of Stockholders on April 23, 2013. The matters voted upon at the meeting and the results of those votes were as follows:

1. Election of Directors.
 
 
 
 
 
 
 
Class of
 
 
 
 
 
Common Stock
Votes
Votes
Votes
Broker
 
to Elect
For
Withheld
Abstaining
Non-Votes
 
 
 
 
 
 
Louis Drapeau
Class A
10,403,948

9,611,785

—
1,607,667

Albert J. Hillman
Class A
10,460,095

9,555,638

—
1,607,667

Deborah J. Neff
Class B
4,803,947

1,567

—
215,657

Alice N. Schwartz
Class B
4,797,140

8,374

—
215,657

Norman Schwartz
Class B
4,798,213

7,301

—
215,657

 
 
2. Ratification of the selection of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2013.
 
Votes
Votes
Votes
Broker
For
Against
Abstaining
Non-Votes
7,096,371
86,795
345
—
 
 
 
 






SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
Date:
April 26, 2013
 
By:
/s/ Christine A. Tsingos
 
 
 
 
 
Christine A. Tsingos
 
 
 
 
 
Executive Vice President, Chief Financial Officer